Navy lab develops long range temperature scanning sensor system

NewsGuard 100/100 Score

A federal research facility in Crane, Indiana, has developed a temperature scanning sensor system and software to help contain the coronavirus.

The U.S. Naval Surface Warfare Center's "sensor agnostic thermal imaging system" was licensed to Greene County General Hospital, according to a news release Tuesday, allowing the staff to detect feverish persons up to 200 yards away.

"Since the tech can detect temperatures in a crowd and from a long distance, it's more flexible than other solutions we had been looking at," said Stacy Burris, the hospital's director of community outreach. "This will cause less interruption in normal operations and allow for more social distancing between staff and anyone coming into the hospital. That could mean less screening staff having to quarantine from exposure."

The U.S. has suffered more than 200,000 deaths from the coronavirus, adding to the one million globally. And public health experts are concerned that a COVID-19 resurgence is mounting as the weather cools and schools and universities reopen.

High body temperature is a key indicator of COVID-19 infection. Burris said the hospital had not found a system for fever detection until they learned of Crane's thermal imaging technology.

Without Crane, we might still be weighing the pros and cons of other solutions. Instead, we're already working to schedule a time for the Crane scientists to set the equipment up."

Stacy Burris, Greene County General Hospital

The software runs on any laptop with USB capability, which is paired with a capture card, a commercial infrared sensor, and a calibrated black body, a temperature reference tool that the software compares with the temperature of a person.

The Navy's software-enabled system, invented by Aaron Cole and Marcin Malec, is also capable of detecting fevers in near real-time - every 0.016 seconds and works on individuals and moving crowds.

Tech transfer opportunity

The Navy's temp-scanning invention, a novel combination of technical knowledge, sensors, and software, was made available to the hospital via a royalty-free license agreement and a cooperative research and development agreement, with support from Radius Indiana, an economic development agency, and TechLink, the Department of Defense's national partnership intermediary for tech transfer.

In April, the Navy lab's Tech Transfer Office, led by Ms. Jenna Dix, made its 300+ patent portfolio available through a new "Rapid Response Licensing Program," giving licensees up to 18 months to develop COVID-19 related applications before paying the royalties normally part of a patent license agreement.

Dix said that tech transfer allows federal R&D to spur growth in the private sector, creating jobs and new tech solutions for the public. Dix said other private companies and entrepreneurs can also license then use, or license to manufacture and sell, the temp-checking tech.

"This technology was made for sailors and Department of Defense civilians, but has applicability just about anywhere," said Dix. "We want Crane's resources to be made available to others-out of the lab and right into the hands of the public."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neural circuits revealed as key regulators in body's immune response, study finds